A nucleus-targeting peptide antagonist towards EZH2 displays therapeutic efficacy for lung cancer
出版年份 2022 全文链接
标题
A nucleus-targeting peptide antagonist towards EZH2 displays therapeutic efficacy for lung cancer
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF PHARMACEUTICS
Volume 622, Issue -, Pages 121894
出版商
Elsevier BV
发表日期
2022-06-06
DOI
10.1016/j.ijpharm.2022.121894
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- In Search of the Long-Desired ‘Copernican Therapeutic Revolution’ in Small-Cell Lung Cancer
- (2020) Noemí Reguart et al. DRUGS
- Inhibition of EZH2 Catalytic Activity Selectively Targets a Metastatic Subpopulation in Triple-Negative Breast Cancer
- (2020) Shira Yomtoubian et al. Cell Reports
- Tazemetostat: First Approval
- (2020) Sheridan M. Hoy DRUGS
- Synthetic CXCR4 Antagonistic Peptide Assembling with Nanoscaled Micelles Combat Acute Myeloid Leukemia
- (2020) Jie Meng et al. Small
- Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study
- (2020) Mrinal Gounder et al. LANCET ONCOLOGY
- Enhanced lymphatic delivery of nanomicelles encapsulating CXCR4-recognizing peptide and doxorubicin for the treatment of breast cancer
- (2020) Xiaocui Fang et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Recent Advances in Cell Penetrating Peptide-Based Anticancer Therapies
- (2019) Justine Habault et al. MOLECULES
- Targeting DNA Methylation and EZH2 Activity to Overcome Melanoma Resistance to Immunotherapy
- (2019) Abdullah Al Emran et al. TRENDS IN IMMUNOLOGY
- Long-term delivery of protein and peptide therapeutics for cancer therapies
- (2019) Sadia Sikder et al. Expert Opinion on Drug Delivery
- Current Diagnosis and Management of Small-Cell Lung Cancer
- (2019) Shuhang Wang et al. MAYO CLINIC PROCEEDINGS
- Therapeutic Approaches Targeting Nucleolus in Cancer
- (2019) Pietro Carotenuto et al. Cells
- Enhancer of zeste homolog 2 (EZH2) inhibitors
- (2018) Nitya Gulati et al. LEUKEMIA & LYMPHOMA
- Unravelling the biology of SCLC: implications for therapy
- (2017) Joshua K. Sabari et al. Nature Reviews Clinical Oncology
- Anti-tumor activity of nanomicelles encapsulating CXCR4 peptide antagonist E5
- (2017) Xiaocui Fang et al. PLoS One
- Targeting EZH2 in cancer
- (2016) Kimberly H Kim et al. NATURE MEDICINE
- A HSP60-targeting peptide for cell apoptosis imaging
- (2016) S Yang et al. Oncogenesis
- Peptide therapeutics: current status and future directions
- (2015) Keld Fosgerau et al. DRUG DISCOVERY TODAY
- Peptide-Based Treatment: A Promising Cancer Therapy
- (2015) Yu-Feng Xiao et al. Journal of Immunology Research
- Peptide-Based Nanostructures for Cancer Diagnosis and Therapy
- (2014) Linna An et al. CURRENT MEDICINAL CHEMISTRY
- EZH2 as a potential target in cancer therapy
- (2014) Michael T McCabe et al. Epigenomics
- EZH2 Promotes E2F-Driven SCLC Tumorigenesis through Modulation of Apoptosis and Cell-Cycle Regulation
- (2013) Roland Hubaux et al. Journal of Thoracic Oncology
- Delivery of drugs to cell membranes by encapsulation in PEG–PE micelles
- (2012) Jing Wang et al. JOURNAL OF CONTROLLED RELEASE
- Histone methylation: a dynamic mark in health, disease and inheritance
- (2012) Eric L. Greer et al. NATURE REVIEWS GENETICS
- Regulation of chromatin by histone modifications
- (2011) Andrew J Bannister et al. CELL RESEARCH
- Ovarian Cancer Stem Cell-Like Side Populations Are Enriched Following Chemotherapy and Overexpress EZH2
- (2011) S. Rizzo et al. MOLECULAR CANCER THERAPEUTICS
- The Polycomb complex PRC2 and its mark in life
- (2011) Raphaël Margueron et al. NATURE
- Overexpression of EZH2 contributes to acquired cisplatin resistance in ovarian cancer cells in vitro and in vivo
- (2010) Sha Hu et al. CANCER BIOLOGY & THERAPY
- Active targeting schemes for nanoparticle systems in cancer therapeutics
- (2008) James D. Byrne et al. ADVANCED DRUG DELIVERY REVIEWS
- Nanoparticle therapeutics: an emerging treatment modality for cancer
- (2008) Mark E. Davis et al. NATURE REVIEWS DRUG DISCOVERY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started